Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1293, pseudogene (RNU6-1293P) is a genomic sequence in humans categorized as a pseudogene. Pseudogenes are DNA sequences that resemble functional genes but are typically non-coding and not expressed as functional products. RNU6-1293P is related to the family of U6 small nuclear RNA genes, which encode essential components of the spliceosome involved in pre-mRNA splicing. However, as a pseudogene, RNU6-1293P is not transcribed or translated into a functional RNA and does not play a direct biological or therapeutic role. It is annotated in genomic databases but lacks known function, associated disease relevance, or drug interactions. This entry is a pseudogene and should not be confused with functional U6 small nuclear RNA genes, which are essential for RNA splicing. There is no evidence that this pseudogene acts as a receptor, enzyme, transporter, or any other classical drug target. While some functional U6 small nuclear RNA genes are involved in the spliceosome and RNA processing, RNU6-1293P is not.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1293, pseudogene (RNU6-1293P).